Therefore, we next examined whether IL-2/anti-CD40 was effective in young vs. elderly AE17 tumor-bearing mice and whether macrophages contributed to the efficacy of IL-2/anti-CD40 immunotherapy. Here, IL2 is linked to neoplasm.